Skip to main content
SpringerLink
Log in

Diagnostik und Therapie der arteriellen Hypertonie im Alter

  • Chapter
Altershypertonie und Begleiterkrankungen

Part of the book series: DUV: Medizin ((DUVM))

  • 16 Accesses

Zusammenfassung

In diesem Abschnitt sollen noch einmal kurz die wichtigsten diagnostischen Maßnahmen bei Altershypertonie dargestellt werden. Es handelt sich um ein Minimalprogramm, daß bei jedem Patienten erforderlich ist [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Vetter W, Steiner A, Huss R. Altershypertonie - Wie abklären? Schweiz Rundsch Med Prax 1991; 80: 689.

    PubMed  CAS  Google Scholar 

  2. Mancia G, Parati G, Pomidossi G, Casadei R, Groppelli A, Sposato E, Zanchetti A. Doctor-elicited blood pressure rises at the time of sphygmomanometric blood pressure assessment persists over repeated visits. J Hypertens 1985; 3: 421–423.

    Article  Google Scholar 

  3. Lewis RR, Padayachec TS, Adriyanayagam RP, Gosling RG. Prevalence of severe internal carotid artery disease in hypertensive elderly patients. J Hypertens 1988; 6 (suppl 1): 33.

    Google Scholar 

  4. Mengden T, Weisser B, Vetter W. Ambulatory 24 hour blood pressure versus self measured blood pressure in pharmacologic trials. J Cardiovasc Pharmacol 1994; 24 Suppl 2: 20–25.

    Google Scholar 

  5. Weisser B, Mengden T, Grune S, Spühler T, Vetter W. Blutdruckselbstmessung: normale and pathologische Werte. Schweiz Rundsch Med Prax 1992; 81 (5): 111–114.

    PubMed  CAS  Google Scholar 

  6. Weisser B, Mengden T, Vetter W. Ambulatory twenty-four-hour blood pressure measurement in pharmacological studies. J Hypertens, 1990; 8 (suppl 6): 87–92.

    Google Scholar 

  7. Media AD, Julius S, Jones KA, Schork NJ, Kneisley J. The Tecumseh Blood Pressure Study. Normative data on blood pressure self-determination. Arch Intern Med 1990; 150: 1209–1213.

    Article  Google Scholar 

  8. Pickering TG, James GD. Some implications of the differences between home, clinic and ambulatory blood pressure in normotensive and hypertensive patients. J Hypertens 1989; 7 (suppl 3): 65–72.

    Google Scholar 

  9. Greminger P, Vetter W. Altershypertonie: Definition, Behandlungsindikation und Abklärungsgang. Schweiz Rundsch Med Prax 84, 44: 1252.

    Google Scholar 

  10. Vetter W, Greminger P. Hypertoniebehandlung bei älteren Patienten. Schweiz Rundsch Med Prax 84, 44: 1277.

    Google Scholar 

  11. Grobbee DE, Hofman A. Does sodium restriction lower blood pressure? Br Med J 1986; 293: 27.

    Article  CAS  Google Scholar 

  12. Mac Gregor GA, Smith SJ, Markandu ND, Banks RA, Sagnella GA. Moderate potassium supplementation in essential hypertension. Lancet 1982; ii: 567.

    Google Scholar 

  13. Mc Carron DA, Morris CD. Blood pressure response to oral calcium in persons with mild to moderate hypertension. Ann Intern Med 1985; 103: 825.

    Google Scholar 

  14. Cairns V, Keil V, Kleinbaum D, Doering A, Steiber J. Alcohol consumption as a risk factor for high blood pressure: The Munich Blood Pressure Study. Hypertension 1984; 6: 124.

    CAS  Google Scholar 

  15. Wlcox G, Benett T, Brown AM, Macdonal IA. Is exercise good for high blood pressure? Br Med J 1982; 285: 767.

    Article  Google Scholar 

  16. Leonetti G, Cuspidi C, Fastidio M, Lonatti L, Chianca R. Arterial hypertension as a risk factor in the elderly and its treatment. J Hypertens 1992; 10 (Suppl 2), 3–7.

    Google Scholar 

  17. Celts H, Fagard R, Staessen J, Thijs L, Amery A. The older hypertensive. Assessment and treatment. Neth J Med 1993; 43, 66–77.

    Google Scholar 

  18. Insua JT, Sacks HS, Lau TS, Lau J, Reitman D, Pagano D, Chalmers TC. Drug treatment of hypertension in the elderly. A meta-analysis. Ann Intern Med 1994; 121, 355–362.

    PubMed  CAS  Google Scholar 

  19. Edmonds D, Huss R, Jeck T, Mengden T, Schubert M, Vetter W. Individualizing antihypertensive therapy with enalapril versus atenolol: the Zürich experience. J Hypertens 1990; 8 (suppl 4): 49–52.

    Google Scholar 

  20. Düsing R, Vetter H. Medikamentöse Therapie der arteriellen Hypertonie. Von der Stufentherapie zum individualisierten Behandlungskonzept. Dtsch Med Wochen schr 1989; 114: 1003–1004.

    Google Scholar 

  21. Mengden T, Vetter W. Blutdruckselbstmessung und Compliance. In: Gleichmann S, Wambach G (Hrsg.). Gesundheitsbewußtsein im Krankenhaus am Beispiel der Hypertonie. Steinkopff Verlag: Darmstadt, 1992, 55–62.

    Chapter  Google Scholar 

  22. Vetter W, Greminger P. Hypertoniebehandlung bei älteren Patienten. Schweiz Rundsch Med Prax 84, 44: 1277.

    Google Scholar 

  23. Cruickshank JM. Coronary flow reserve and J-curve relation between diastolic blood pressure and myocardial infarction. Br Med J 1988; 297: 1227.

    Article  CAS  Google Scholar 

  24. O’malley K, Kelly JG. Pharmacokinetics in the elderly. In: Amery A, Staessen J (Hrsg.). Hypertension in the elderly. Elsevier, Amsterdam 1989.

    Google Scholar 

  25. Vetter W, Greminger P. Hypertoniebehandlung bei älteren Patienten. Schweiz Rundsch Med Prax 84, 44: 1277.

    Google Scholar 

  26. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669–677.

    Article  PubMed  CAS  Google Scholar 

  27. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure; results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429.

    Article  Google Scholar 

  28. Laragh JH. Concept of anti-renin system therapy: historic perspective. Am J Med 1984; 77 (2A): 1.

    PubMed  CAS  Google Scholar 

  29. Bühler FR, Bolli P, Kiowski W, Erne P, Hulthen UL, Block LH. Renin profiling to select antihypertensive baseline drugs: renin-inhibitors for high-renin and calcium entry blockers for low-renin patients. Am J Med 1984; 77 (2A): 36.

    PubMed  Google Scholar 

  30. Applegate WB, Phillips HL, Schnaper H, Shepherd AMM, Schocken D, Challop Luhr J, Koch GG, Park GD. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 151, 1817, 1991

    Article  PubMed  CAS  Google Scholar 

  31. Waeber B, Bornand E, Vuichard P, Nussberger J, Brunner HR. Enalapril: results of a multicenter trial in Switzerland with special attention to the elderly hypertensives. In: Brunner HR (Hrsg.). Enalapril in der Behandlung der Hypertonie, Hamburger Symposium. Georg Thieme: Stuttgart 1987, 69–73.

    Google Scholar 

  32. Lüscher TF, Waeber B. Swiss Hypertension Society. Calcium antagonists as first-line therapy in hypertension: results of the Swiss isradipine study. J Cardiovasc Pharmacol 18 (suppl 3 ): 1–3.

    Google Scholar 

  33. Kuramoto K, Yamada K, Matsushita H. Age and efficacy of calcium entry blocker in essential hypertension-double blind trial using nicardipine. Jpn J Geriatr 1982; 104: 1346.

    Google Scholar 

  34. Leonetti G. Calcium antagonists in the treatment of arteriel hypertension in the elderly. In: Amery A, Staessen J (Hrsg.). Hypertension in the elderly. Elsevier: Amsterdam 1989.

    Google Scholar 

  35. Klaus D. Calcium antagonists in the treatment of hypertension. J Cardiovasc Pharmacol 1992; 20 (Suppl 6): 6.

    Google Scholar 

  36. Bühler FR, Hulthen UL, Kiowski W, Bolli P. Greater antihypertensive efficacy of the calcium channel inhibitor verapamil in older and low renin patients. Clin Sci 1982; 63: 439.

    Google Scholar 

  37. Kiowski W, Bühler FR, Fadyomi MO, Erne P, Müller FB, Hulthen UL, Bolli P. Age, Diuretika race, blood pressure, and renin: predictors for antihypertensive treatment with calcium antagonists. Am J Cardiol 1985; 56: 81H.

    Google Scholar 

  38. Lopez LM, Mehta TC, Fagan PC, Deedwania PC, Birkett JP. Is antihypertensive therapy with calcium channel blockers more effective in the elderly than in younger subjects? In: Proceedings, Annual Meeting of the American Society of Hypertension, New York, 1987, p A94.

    Google Scholar 

  39. Deutsche Liga zur Bekämpfung des hohen Blutdrucks. Empfehlungen zur Hochdruckbehandlung in der Praxis 1994. Heidelberg, Postfach 102040.

    Google Scholar 

  40. Veterans Administration Co-Operative Study on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. I. Results in patients with diastolic pressure averaging 115 through 129 mmHg. J Am Med Assoc (JAMA) 1967; 202: 1028.

    Article  Google Scholar 

  41. Veterans Administration Co-Operative Study on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic pressure averaging 90 through 114 mmHg. J Am Med Assoc (JAMA) 1970; 213: 1143.

    Article  Google Scholar 

  42. Veterans Administration Co-Operative Study on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Ill. Influence of age, diastolic pressure and prior cardiovascular disease: further analysis of side effects. Circulation 1972; 45: 991.

    Article  Google Scholar 

  43. Report by the Management Committee. The Australian therapeutic trial on mild hypertension. Lancet 1980; 1: 1261.

    Google Scholar 

  44. Hypertension Detection and Follow-up Program Cooperative group. Five years’ finding of the hypertension detection and follow-up program. J Am Med Assoc (JAMA) 1979; 242: 2562.

    Google Scholar 

  45. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, DE Schaepdryver A, Dollery C, Fagard R, Forette F, Forte J, Hamdy R, Henry FL, Joosens JV, Leonetti G, Lund-Johansen O, O’malley K, Petrie J, Strasser T, Tuomilehto J, Williams B. Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial. Lancet 1985; 1, 1349.

    Article  PubMed  CAS  Google Scholar 

  46. Grimm RH, Leon AS, Hunningkake DB, Lenzk, Hannan P, Blavkburn H. Effects of thiazide diuretic on plasma lipids and lipoproteins in mildly hypertensive patients: a double-blind controlled trial. Ann Intern Med 1981; 94: 7.

    PubMed  Google Scholar 

  47. Weisser B, Ripka O. Long-term diuretic therapy: effects of dose reduction on antihypertensive efficacy and counterregulatory systems. J Cardiovasc Pharmacol 1992, 19: 361–366.

    Article  PubMed  CAS  Google Scholar 

  48. Lund-Johansen P. Hemodynamic changes in longterm diuretic therapy of essential hypertension. Acta Med Scand 1970; 187: 590.

    Google Scholar 

  49. Pricher BNC, Owens CWI, Cruickshank JM. Pharmacodynamics and pharmacokinetics of beta-adrenocaptor blockers in the elderly. In: Amery A, Staessen J (Hrsg.). Hypertension in the elderly. Elsevier: Amsterdam 1989.

    Google Scholar 

  50. Bühler FR, Burkart F, Lütold BE, Kong M, Marbet G, Pfisterer M. Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. Am J Cardiol 1975; 36: 653.

    Article  PubMed  Google Scholar 

  51. Greenberg G, Brennan PJ, Mial WE. Effects of diuretic and beta-blocker therapy in the Medical Research Council trial. Am J Med 1984; 76: 45.

    Article  PubMed  CAS  Google Scholar 

  52. Bühler FR, Anderson O, Berglund G, VAN Brummelen P, Brunner HR, DAL Plau C, Fogari R, Prichard BNC, Reid JH, Zanchetti A. Double-blind comparison of the cardioselective bisoprolol and atenolol: the Bisoprolol International Multicentre Study (BIMS). In: Abstracts, 11th Scientific Meeting of the International Society of Hypertension, Heidelberg 1986, 645.

    Google Scholar 

  53. Zacharias FJ. Long-term clinical experience with atenolol. R Soc Med Int Cong Symp Ser 1979; 19: 75.

    Google Scholar 

  54. Weidmann P, Beretre-Piccoli C, Ziegler WH, Keusch G, Gluck Z, Reubi FC. Age versus urinary sodium forjudging renin aldosterone and catecholamine levels: studies in normal subjects and patients with essential hypertension. Kidney Int 1978; 14: 619.

    Article  PubMed  CAS  Google Scholar 

  55. O’malley K, O’brien E. Management of hypertension in the elderly. N Engl J Med 1980; 302: 1397.

    Article  PubMed  Google Scholar 

  56. Graham RM, Pettinger WA. Prazosin. N Engl J Med 1979; 300: 232.

    Article  PubMed  CAS  Google Scholar 

  57. Caris TN. Hypertension in older patients: what drugs to use and when? Geriatrics 1982; 37: 38.

    PubMed  CAS  Google Scholar 

  58. Vetter W, Greminger P. Hypertoniebehandlung bei älteren Patienten. Schweiz Rundsch Med Prax 84, 44: 1277.

    Google Scholar 

  59. Tuck ML. The sympathetic nervous system in essential hypertension. Am Heart J 1986; 112: 877.

    Article  PubMed  CAS  Google Scholar 

  60. Van Zwieten PA. Pharmacology of centrally acting hypotensive drugs. Br J Clin Pharmacol 1980; 10: 13.

    Article  Google Scholar 

  61. Hoobler SW, Sagatume E. Clonidine hydrochloride in the treatment of hypertension. Am J Cardiol 1971; 28: 67.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Münster, Deutschland

    Prof. Dr. G. A. E. Rudolf

  2. Bonn, Deutschland

    Prof. Dr. H. Vetter & Priv.-Doz. Dr. B. Weißer

Authors
  1. Prof. Dr. G. A. E. Rudolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. H. Vetter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Priv.-Doz. Dr. B. Weißer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Fachmedien Wiesbaden

About this chapter

Cite this chapter

Rudolf, G.A.E., Vetter, H., Weißer, B. (1996). Diagnostik und Therapie der arteriellen Hypertonie im Alter. In: Altershypertonie und Begleiterkrankungen. DUV: Medizin. Deutscher Universitätsverlag, Wiesbaden. https://doi.org/10.1007/978-3-663-01653-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-663-01653-3_5

  • Publisher Name: Deutscher Universitätsverlag, Wiesbaden

  • Print ISBN: 978-3-663-01654-0

  • Online ISBN: 978-3-663-01653-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation